Trials / Completed
CompletedNCT00815048
Remifentanil and Atropine for Intubation in Neonates
Remifentanil and Atropine for Intubation in Neonates; a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- King Saud University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that the use of a combination of Atropine and Remifentanil will safely facilitate non emergent intubation procedure as effectively as the protocol of Atropine, Fentanyl, and Succinylcholine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atropine/Remifentanil | Atropine 20mcg/kg Remifentanil 3mcg/kg |
| DRUG | Fentanyl/Atropine/Succinylcholine | Atropine 20mcg/kg Fentanyl 2mcg/kg Succinylcholine 2mg/kg |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2008-12-29
- Last updated
- 2008-12-29
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00815048. Inclusion in this directory is not an endorsement.